Hims & Hers Health, Inc.

Hims & Hers Health, Inc. (NYSE: HIMS) is a consumer health and telehealth company that entered the public markets in January 2021 via a merger with Oaktree Acquisition Corp., a blank-check vehicle sponsored by Oaktree Capital Management. The company operates a direct-to-consumer platform offering personal care and wellness products across men's and women's health categories, encompassing both prescription and over-the-counter treatments. HIMS filed an 8-K with the SEC on June 15, 2026, continuing a steady cadence of regulatory disclosures as an established post-merger public company on the New York Stock Exchange. For full filing history, sponsor data, and deal analytics on HIMS, sign up for SpacDesk.